How to restore testosterone naturally using HPG axis support. Enclomiphene, clomiphene, and kisspeptin protocols with blood work targets for LH, FSH, estradiol, and testosterone.
Why Some Men Choose Not to Use TRT Testosterone replacement therapy (TRT) is effective, well-studied, and appropriate for many men with hypogonadism. But TRT shuts down endogenous testosterone production -- the pituitary stops sending LH and FSH signals to the testes because exogenous testosterone creates negative feedback on the HPG axis. For men who want to preserve fertility, maintain testicular size, or simply keep their endocrine system working on its own, TRT-free testosterone optimization is a meaningful alternative. The key: most men with low testosterone in their 30s-50s have secondary hypogonadism, not primary. Their testes work fine -- the upstream signal is the problem.
The hypothalamic-pituitary-gonadal (HPG) axis has three checkpoints:
Hypothalamus to Pituitary: GnRH tells the pituitary to release LH and FSH.
Pituitary to Testes: LH stimulates Leydig cells to produce testosterone. FSH stimulates Sertoli cells for sperm production.
Testes to Blood: Testosterone is produced and circulates. Some converts to estradiol via aromatase.
Interpreting your panel:
Low T + Low LH + Low FSH = Secondary hypogonadism. The pituitary is not signaling adequately. HPG axis support will work.
Low T + High LH + High FSH = Primary hypogonadism. The testes are failing despite adequate signaling. TRT is likely necessary.
Low T + Normal LH + Normal FSH = Partial secondary or functional hypogonadism. Lifestyle factors may be primary drivers.
Enclomiphene is the trans-isomer of clomiphene. It blocks estrogen receptors at the hypothalamus and pituitary, increasing GnRH pulsatility and downstream LH/FSH secretion.
Mechanism: By blocking estrogen feedback at the hypothalamus, enclomiphene removes the brake on GnRH and LH pulsatility. The pituitary gets the signal to produce more LH, which tells the testes to produce more testosterone.
Standard protocol: 25 mg oral daily. Some physicians use 12.5 mg in sensitive patients.
Expected lab response at 6-12 weeks:
Kisspeptin is an upstream hypothalamic peptide that drives GnRH pulsatility. Kisspeptin neurons are the primary gatekeepers of the HPG axis -- without adequate kisspeptin signaling, GnRH cannot fire properly, LH does not peak, and testosterone production falters.
Protocol for HPG axis support:
Primary markers:
Secondary markers:
MyProtocolStack tracks all relevant HPG axis biomarkers -- LH, FSH, total and free testosterone, estradiol, SHBG, prolactin -- with optimal ranges calibrated for performance rather than the wide normal ranges on standard lab reports.
Log your protocol alongside your lab draws and StackAI will analyze whether your HPG axis is responding appropriately and flag concerning estradiol patterns.
The information in this article is for educational purposes only. It does not constitute medical advice. Always consult a licensed healthcare provider before starting any protocol.
Written by Ryan -- Founder, MyProtocolStack. Last Updated: April 2026.
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.
Start Free →